Vaccines, Pharmaceutical Policy & FDA’s Next Moves
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Vaccines, Pharmaceutical Policy & FDA’s Next Moves
-
Narrated by:
-
By:
About this listen
Wayne chats with Deb Autor, CEO of Healthcare Innovation Catalysts, and Paul Offit, M.D., Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at the Children’s Hospital of Philadelphia. You’ll hear their thoughts on vaccine development, policy, testing, and funding, including COVID vaccines; the new Commissioner’s National Priority Voucher Program; the Sarepta gene therapy episode; leadership transitions at CDER and CBER; AI in pharmaceutical regulation; and much more.
In our headlines segment, Wayne delves into these major developments:
Pharma: Vinay Prasad back as CBER head after ousting
Devices: Troubles continue with FDA’s new AI tool, Elsa
Food: FDA and USDA publish joint RFI to help define ultra-processed foods
Cosmetics: Anxiety over U.S.-imposed tariffs sparks shopper panic in late July
In our Resource Links segment, we list key documents in our four core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.
Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net.
Music by Dvir Silver from Pixabay.